[1]CurrentPatentAssignee:BIOCRYSTPHARMACEUTICALSINC-WO2021/72198,2021,A1Locationinpatent:Page/Pagecolumn81;84;231;232
1214899-85-0
60301-20-4
1260854-85-0
1626335-95-2
701910-33-0
100047-61-8 | 4,5-Dimethyl-isoxazole-3-carboxylic acid | AA0000LR | MFCD05667138
1001-75-8 | 4-Methylpent-4-enoic acid | AA0000V5 | MFCD06208588
1002-19-3 | Propanamide, 3,3'-dithiobis- | AA00014W | MFCD00052129
1003-56-1 | 3-Methyl-2-pyridone | AA0001FM | MFCD00039704
1003708-42-6 | 3-Fluoro-5-formylbenzonitrile | AA0001OA | MFCD04974123
1004-24-6 | (4-Methylenecyclohexyl)methanol | AA0001UC | MFCD00045564
1005631-56-0 | 1H-Pyrazole, 1-(2,2-diethoxyethyl)-4-methyl- | AA00029D | MFCD05667116
1007089-84-0 | 3-(Chloromethyl)-5-methylpyridine, HCl | AA0002LZ | MFCD11656303
100836-85-9 | (R)-(+)-2-Benzyloxypropionic acid | AA0002W5 | MFCD06799065
1009335-36-7 | (3R,5R)-5-(Hydroxymethyl)pyrrolidin-3-ol hydrochloride | AA000363 | MFCD17676315